0
Clinical Trial ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 1 ? Systematic review or meta-analysis. Synthesizes findings across many studies. Strongest evidence. Detection Methods Environmental Sources Human Health Effects Nanoplastics Policy & Risk Sign in to save

Microplastics: Clinical Trials Perspectives

International Journal of Environment and Health Sciences 2022
Ratul Kumar Das, O Alimi, J Farner Budarz, L Hernandez, N Tufenkji, H Environmental Pollution Leslie, M Van Velzen, S Brandsma, A Vethaak, J Garcia-Vallejo, M Lamoree, M Prokic, B Gavrilovic, T Radovanovic, J Garvic, G Petrovic, S Despotovic, C Faggio, A Ragusa, A Svelato, C Santacroce, P Catalano, V Notarstefano, O Carnevali, F Papa, M Rongioletti, F Baiocco, S Draghi, E D'amore, D Rinaldo, M Matta, E Giorgini, G Van Norman

Summary

This mini review covers the current state of clinical research on microplastics in the human body. Tiny plastic particles have been found in human blood and organs, but studying their effects is challenging due to a lack of standardized methods and ethical guidelines for human trials. The paper highlights that while lab and animal studies provide early data, much more work is needed to understand what microplastics do inside us.

Models
Study Type In vivo

Plastic pollution has emerged as one of the global challenges for the humanity. Plastics particles of millimeter and micrometer dimensions have been detected everywhere in the environment. Detection of tiny plastic particles in human blood and different organs has caused serious concerns and awareness in the society. Research activities have been initiated globally f or better understanding the possible routes of entry and translocation of micro-and nano-plastics in human body. In vitro and in vivo studies have generated some primary data on these aspects. However, the major challenges in gathering data from clinical studies are lack of established methodology for designing ethically correct experiments, detection and identification of plastic particles and regulatory guidelines that needs to be designed specifically for micro-and nanoplastics. In this mini review article, readers are navigated through the recent updates on the clinical studies with microplastics and current challenges with some critical inputs.

Share this paper